FREE Account Opening + No Clearing Fees
Loading...

Healthcare Global IPO vs Thyrocare Technologies IPO

Comparision between Healthcare Global IPO and Thyrocare Technologies IPO.

IPO Details

Healthcare Global IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Thyrocare Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Healthcare Global IPO is up to ₹649.64 Cr whereas the issue size of the Thyrocare Technologies IPO is up to ₹479.21 Cr. The final issue price of Healthcare Global IPO is ₹218.00 per share and of Thyrocare Technologies IPO is ₹446.00 per share.

  Healthcare Global IPO Thyrocare Technologies IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹205.00 per share ₹420.00 per share
Issue Price (Upper) ₹218.00 per share ₹446.00 per share
Issue Price (Final) ₹218.00 per share ₹446.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 65 shares 33 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size 1,07,44,708 shares
OFS Issue Size (Amount)
Issue Size Total 2,98,00,000 shares 1,07,44,708 shares
Issue Size Total (Amount) up to ₹649.64 Cr up to ₹479.21 Cr

IPO Timetable

Healthcare Global IPO opens on Mar 16, 2016, while Thyrocare Technologies IPO opens on Apr 27, 2016. The closing date of Healthcare Global IPO and Thyrocare Technologies IPO is Mar 18, 2016, and Apr 29, 2016, respectively.

  Healthcare Global IPO Thyrocare Technologies IPO
Anchor Bid Date
Issue Open Mar 16, 2016 Apr 27, 2016
Issue Close Mar 18, 2016 Apr 29, 2016
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Healthcare Global IPO P/E ratio is , as compared to Thyrocare Technologies IPO P/E ratio of .

  Healthcare Global IPO Thyrocare Technologies IPO
Financial

Particulars

For the year/period ended (in Rs. Million)
31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12 31-Mar-11
Total Liabilities 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Assets 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Revenue 4,244.41 3,525.94 2,939.52 2,051.67 1,601.43
Profit After Tax (PAT) (23.66) (394.98) (71.58) (40.02) 34.40

Particulars

For the year/period ended (in Rs. Million)
31-Dec-15 31-Mar-15
Total Revenue 1,804.73 1,903.38
Profit After Tax (PAT) 400.21 432.54
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Healthcare Global IPO retail investors (RII) are offered 29,80,000 shares while in Thyrocare Technologies IPO retail investors are offered 29,80,000 shares. Qualified institutional buyers (QIB) are offered 89,40,000 shares in Healthcare Global IPO and 21,48,942 shares in Thyrocare Technologies IPO.

  Healthcare Global IPO Thyrocare Technologies IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 89,40,000 shares 21,48,942 shares
NII 44,70,000 shares 16,11,707 shares
RII 29,80,000 shares 37,60,648 shares
Employee
Others
Total 1,63,90,000 shares 75,21,297 shares

Bids Received (Subscription)

Healthcare Global IPO subscribed 1.56x in total, whereas Thyrocare Technologies IPO subscribed 73.55x.

  Healthcare Global IPO Thyrocare Technologies IPO
QIB (times) 2.36x 73.18x
NII (times) 0.43x 225.30x
Big NII (times)
Small NII (times)
RII (times) 0.83x 8.73x
Employee (times)
Other (times)
Total (times) 1.56x 73.55x

Comments

Add a public comment...